Patents
Patents for C40B 20 - Methods specially adapted for identifying library members (1,281)
06/2001
06/07/2001CA2392919A1 Systems and methods to facilitate multiple order combinatorial chemical processes
05/2001
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
04/2001
04/26/2001WO2001029537A2 Method and apparatus for monitoring solid phase chemical reactions
04/12/2001WO2001025486A1 Methods for identifying rna binding compounds
04/12/2001WO2001025188A1 Novel carbamates and ureas
04/12/2001WO2001025171A1 Chemical constructs
04/12/2001WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2
04/12/2001CA2386540A1 Novel carbamates and ureas
04/12/2001CA2386239A1 Methods for identifying rna binding compounds
04/11/2001EP1089749A1 Novel therapeutic agents for membrane transporters
03/2001
03/28/2001EP1086066A1 Muscarinic receptor antagonists
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085890A1 Novel sodium channel drugs and uses
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085879A2 Multibinding agents that modulate the 5-ht transporter
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001EP1085845A2 Multibinding inhibitors of cyclooxygenase-2
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/21/2001EP1083980A2 Modulation of molecular interaction sites on rna and other biomolecules
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/08/2001WO2001015800A1 Method and device for performing operations at charged microlocations
03/08/2001WO2000017655A8 Water-soluble fluorescent semiconductor nanocrystals
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001EP1079919A1 Method of synthesizing a plurality of products
02/2001
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/14/2001EP1075455A2 Method and device for nonsynthetic deconvolution
02/07/2001EP1073905A1 Methods of selecting internalizing antibodies
02/01/2001WO2001007457A1 Antisense modulation of pten expression
02/01/2001CA2379659A1 Antisense modulation of pten expression
01/2001
01/24/2001EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
01/17/2001EP1068216A2 Libraries of oligomers labelled with different tags
12/2000
12/14/2000WO2000075373A2 Combinatorial decoding of random nucleic acid arrays
12/14/2000CA2374390A1 Combinatorial decoding of random nucleic acid arrays
12/07/2000WO2000072969A1 Apparatus and method for the precise location of reaction plates
11/2000
11/16/2000CA2721199A1 Isolating biological modulators from biodiverse gene fragment libraries
11/02/2000EP1047942A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
10/2000
10/26/2000WO2000062919A1 Modular chemical microsystem
10/25/2000EP1045819A1 Method for producing mass-coded combinatorial libraries
10/19/2000WO2000061281A1 Encoding scheme for solid phase chemical libraries
10/19/2000DE19917398A1 Micromodular, rapidly-assembled, computer-controlled, virtual chemical plant with full complement of unit operations, is used e.g. to assess processes for new and hazardous products and to optimize yield
10/19/2000CA2367541A1 Encoding scheme for solid phase chemical libraries
09/2000
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000CA2582809A1 Replica amplification of nucleic acid arrays
09/08/2000WO2000052140A1 Assays for inhibitors of ftsh
09/08/2000CA2364384A1 Assays for inhibitors of ftsh
08/2000
08/31/2000WO2000017103A3 Inventory control
08/17/2000WO2000047598A1 Method and apparatus for compound library preparation using optical modulator
08/10/2000WO2000033084A3 Arrays of organic compounds attached to surfaces
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
07/2000
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/20/2000WO2000042213A1 A novel method for designing protein kinase inhibitors
07/20/2000CA2360581A1 A novel method for designing protein kinase inhibitors
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/13/2000WO2000017642A3 Biological applications of semiconductor nanocrystals
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/2000
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/08/2000WO2000033084A2 Arrays of organic compounds attached to surfaces
06/02/2000WO2000014545A9 Multihued labels
05/2000
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999058476A9 Method and device for nonsynthetic deconvolution
04/2000
04/27/2000WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors
04/25/2000US6054047 Apparatus for screening compound libraries
04/20/2000WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors
04/20/2000WO1999058947A9 Modulation of molecular interaction sites on rna and other biomolecules
04/11/2000US6048698 Producing products by bond formation of a reactant bound to nucleic acid and a free reactant, then contacting product library with target to partition products by ability to perform preselected function
03/2000
03/30/2000WO2000017655A1 Water-soluble fluorescent semiconductor nanocrystals
03/30/2000WO2000017642A2 Biological applications of semiconductor nanocrystals
03/30/2000WO2000017398A1 Parallel selex
03/30/2000WO2000017103A2 Inventory control
03/30/2000CA2344288A1 Parallel selex
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/16/2000WO2000014545A1 Multihued labels
03/16/2000WO1999063932A9 Multibinding agents that modulate the 5-ht transporter
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000WO1999058476A3 Method and device for nonsynthetic deconvolution
02/2000
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1999063932A3 Multibinding agents that modulate the 5-ht transporter
02/03/2000WO1999058947A3 Modulation of molecular interaction sites on rna and other biomolecules
02/01/2000US6020199 Antisense modulation of PTEN expression
01/2000
01/27/2000WO1999063930A3 Novel angiotensin receptor modulators and their uses
01/20/2000WO1999060007A3 Libraries of oligomers labelled with different tags
12/1999
12/29/1999WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
1 ... 2 3 4 5 6 7 8 9 10 11 12 13